Skip to main content
Also available in 2 other languages

Tiếng Việt简体中文

Beginner 9 min read

What Is R-CHOP Chemotherapy?

R-CHOP: what the regimen or drug class includes, why it is used, and what to ask.

This is general education — it cannot tell you what to do in your situation.

Instructions and urgent-contact thresholds vary by treatment and care team. If you are in treatment, follow the instructions your oncology team gave you, and contact them about any new or worsening symptom. If you think you may be having a medical emergency, call your local emergency number.

NCI source:National Cancer Institute - R-CHOP

Review status: AI-assisted, editorial review complete. Not reviewed by a clinician. How we check pages

The short answer

R-CHOP is a cancer treatment name people often see in a portal, consent form, or infusion schedule. It includes rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and may be used for certain non-Hodgkin lymphomas, depending on subtype and stage. This guide explains the name, schedule questions, side effects, and decision points.

  • The letters come from older names: H is doxorubicin (once hydroxydaunomycin) and O is vincristine (once sold as Oncovin). R, rituximab, is an antibody rather than chemotherapy.

  • Two checks come before cycle one — a heart function test, because doxorubicin can damage heart muscle years later, and a hepatitis B blood test, which MedlinePlus says your doctor will order before rituximab.

  • Each drug has a signature warning: infusion reactions with rituximab, heart symptoms with doxorubicin, nerve symptoms and constipation with vincristine, blood in the urine with cyclophosphamide.

  • NCI reports that for advanced-stage diffuse large B-cell lymphoma, 50% are cured with rituximab plus doxorubicin-based chemotherapy, typically Pola-R-CHP or R-CHOP.

Choose how you want to read this

The whole article, with every detail and caution.

Why the letters do not match the drug names

R-CHOP is a five-drug treatment for some kinds of lymphoma. This page is for anyone starting it, or caring for someone who is. It covers what each drug does, the tests before treatment, and which warning signs need a call.

R-CHOP looks like a typo. The letters come from older brand and chemical names. NCI spells out all five:

  • R is rituximab. It is not chemotherapy. It is an antibody that finds CD20-positive B cells.
  • C is cyclophosphamide.
  • H is doxorubicin hydrochloride. An older name for it was hydroxydaunomycin. That is where the H came from.
  • O is vincristine sulfate. It was once sold as Oncovin. That brand name gave us the O.
  • P is prednisone, a steroid.

NCI lists R-CHOP for B-cell non-Hodgkin lymphoma. That includes diffuse large B-cell lymphoma. It also includes advanced follicular lymphoma as a first treatment, and Waldenstrom macroglobulinemia.

How the five parts work together

Rituximab locks onto CD20, a protein on the surface of B cells. That marks the cell to be destroyed.

Doxorubicin belongs to a drug family called the anthracyclines. NCI says it blocks an enzyme called topoisomerase II. Cells need that enzyme. Blocking it damages the DNA of fast-growing cells.

Cyclophosphamide and vincristine attack dividing cells in other ways. Prednisone is a steroid.

What has to be checked before cycle one

Two tests are not optional, and both trace to specific drug risks.

A heart function test. MedlinePlus warns that doxorubicin may cause serious or life-threatening heart problems. They can start at any time during treatment. They can also start months or years after it ends. Doctors check heart function before and during therapy. They use an electrocardiogram and an echocardiogram. Ask for the number, usually reported as an ejection fraction, and keep it. Future doctors will want the baseline.

Hepatitis B testing. MedlinePlus says your doctor will order a blood test before rituximab. The drug can make a hepatitis B infection more serious or life-threatening. This is not a formality. It can flare in people who were told decades ago that an old infection had cleared.

The warnings worth memorizing

Each drug carries a distinct signature problem. Learn which symptom belongs to which.

Rituximab: infusion reactions. These can happen during the infusion or within 24 hours after it. Watch for hives, rash, or itching, swelling of the lips, tongue, or throat, or trouble breathing. If swelling of the lips, tongue, or throat or trouble breathing starts after you have already gone home, treat it as a 911 emergency. That combination is what anaphylaxis (a severe, whole-body allergic reaction) looks like, and it does not wait for office hours.

If any of it starts while the drip is running, say so out loud right away. The nurse is right there, and the infusion can be paused in seconds. The team has antihistamines, steroids, and epinephrine on hand.

Doses are given in a medical facility with monitoring. Premedication (medicine given beforehand) is used to blunt the reaction. That is why most reactions happen during the infusion rather than after.

Rituximab: two rarer problems. Report painful sores or ulcers on skin, lips, or mouth, blisters, or peeling skin. There is a second, rarer problem. It is called progressive multifocal leukoencephalopathy, a rare brain infection. MedlinePlus says it usually causes death or severe disability. Its warning signs are new or sudden confusion, or changes in thinking. Others are trouble talking or walking, and loss of balance.

Doxorubicin: the heart. Report shortness of breath or trouble breathing. Report swelling of the hands, feet, ankles, or lower legs. Report a fast, irregular, or pounding heartbeat. These matter years later, not only during treatment.

Doxorubicin: the vein. The drug can leak into surrounding tissue and cause severe irritation or damage. Report pain, itching, redness, swelling, blisters, or sores at the injection site.

Vincristine: the nerves. Report pain, numbness, burning, or tingling in the hands or feet. Report trouble walking, or unsteady walking. Report loss of the ability to move or feel part of the body. Constipation is listed as a serious side effect, not a nuisance. Vincristine slows the bowel.

Vincristine: route. MedlinePlus states it is to be given only into a vein. Like doxorubicin, it damages tissue if it leaks.

Cyclophosphamide: the bladder. Call immediately for pink or red urine, or blood in the urine. Drink plenty of fluids and urinate often during treatment. That flushes out the drug's irritating byproducts. Otherwise they sit in the bladder.

Counts, fever, and the number to post on the fridge

All the chemotherapy components lower blood counts. MedlinePlus says doxorubicin can cause a severe drop in blood cells from the bone marrow. Signals to report are sore throat, fever, and chills. So are unusual bruising or bleeding, and tarry stools. Black, tarry stools go on the 911 line in the list below.

MedlinePlus and CDC give 100.4°F (38°C) or higher as the fever threshold. If your own team gave you a lower number, use theirs.

Reaching it between cycles is an emergency, not a next-morning call. Phone your cancer team right then. If nobody answers quickly, get to an emergency department and tell them you are on R-CHOP. That number, and your after-hours line, are the two things to put on the fridge.

Long-term risks to discuss up front

Two deserve a real conversation before cycle one, because the window to act on one of them closes.

MedlinePlus states that cyclophosphamide may cause permanent infertility in men and women. It can interfere with periods and with sperm production. Pregnancy is still possible during treatment. If children are a possibility for you, fertility preservation is a before-treatment decision.

Both cyclophosphamide and doxorubicin carry a risk of second cancers. MedlinePlus notes doxorubicin may raise the risk of leukemia. The risk is higher at high doses, or when it is combined with certain other chemotherapy drugs.

How well it works, and what is replacing it

NCI's assessment for diffuse large B-cell lymphoma is direct. Localized disease can be cured with combined-modality therapy. It can also be cured with chemotherapy alone, typically R-CHOP. For advanced-stage disease, 50 percent are cured with rituximab plus doxorubicin-based chemotherapy. That usually means Pola-R-CHP or R-CHOP.

Notice that Pola-R-CHP is now listed alongside R-CHOP. That regimen adds polatuzumab and drops the O. Vincristine comes out. If your team proposes it, the nerve-related side effects above change.

A third regimen appears for a specific situation. NCI describes dose-adjusted R-EPOCH. In primary mediastinal large B-cell lymphoma, it or R-CHOP produced high cure rates. It also avoided radiation to the chest.

Questions for your oncologist

  • Is my regimen R-CHOP, Pola-R-CHP, or something else, and why that one?
  • How many cycles are planned, and how far apart?
  • What was my baseline ejection fraction, and when is it rechecked?
  • Was I tested for hepatitis B, and what did it show?
  • Will I get growth factor support to protect my white counts?
  • Is radiation planned after chemotherapy?
  • Should I see a fertility specialist before cycle one?
  • What is my exact fever threshold and after-hours number?

When to get help sooner

  • Call 911 or go to an emergency department if your lips, tongue, or throat swell, or you struggle to breathe, during a rituximab infusion or in the 24 hours after one. Do not drive yourself.
  • Call 911 or go to an emergency department if you have chest pain, a fast or pounding irregular heartbeat, or breathlessness at rest. Doxorubicin damages heart muscle, and this can appear during treatment or years later. Do not drive yourself.
  • Call the oncology line at once if you have a temperature of 100.4°F (38°C) or higher, or shaking chills, at any point between cycles. CDC says to call right away and calls a fever during chemotherapy a medical emergency. This needs a live answer now, not a message left for the clinic. Go to an emergency department if that answer does not come.
  • Call 911 or go to the nearest emergency department if you have black, tarry stools, vomit blood or material that looks like coffee grounds, or have heavy bleeding. Do not drive yourself if you feel very unwell. MedlinePlus lists these as reasons to call at once (MedlinePlus).
  • Call your care team right away, at any hour, if you become newly confused, have trouble talking or walking, or lose your balance. These are the warning signs of the rare brain infection linked to rituximab, and MedlinePlus says to call your doctor immediately (MedlinePlus). If confusion or trouble speaking comes on suddenly, over minutes or hours, call 911, because that can also be a stroke. Do not drive yourself.
  • Call your care team right away if you have unusual bruising or bleeding, or pink or red urine. Blood in the urine is the cyclophosphamide bladder effect, and MedlinePlus says to call immediately.
  • Call your care team the same day if you have not passed stool for several days and your belly is swollen or painful. Vincristine slows the bowel, and constipation is listed as a serious effect here, not a nuisance.
  • Call your care team right away if numbness, burning, or tingling in the hands or feet is new or getting worse, or walking has become unsteady.
  • Call your care team within a day or two if you develop mouth or skin sores, blisters, or peeling skin, or pain, redness, and swelling at the injection site.

Sources

A woman laughs with a nurse during an infusion, IV line visible

Common questions

What does each letter in R-CHOP stand for?

Rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone. The H and O look wrong because they come from older names — hydroxydaunomycin for doxorubicin, and the brand Oncovin for vincristine.

Which lymphomas is R-CHOP used for?

NCI lists B-cell non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, advanced follicular lymphoma as a first treatment, and Waldenström macroglobulinemia.

What has to be checked before the first cycle?

Heart function, using an electrocardiogram and echocardiogram, because MedlinePlus warns doxorubicin can cause serious heart problems during treatment or months to years afterward. And a hepatitis B blood test, which MedlinePlus says your doctor will order before rituximab because the drug can make an old infection flare.

What fever number should I call about?

Use 100.4 °F (38 °C), the number MedlinePlus and CDC give, unless your team gave you a lower one. Reaching it on R-CHOP means calling your cancer team at once, at any hour, and going to an emergency department if you cannot get through. CDC says an infection during chemotherapy can be life-threatening.

Is R-CHOP still the standard?

Not always. NCI now lists Pola-R-CHP alongside it for advanced diffuse large B-cell lymphoma; that regimen adds polatuzumab and drops vincristine, which changes the nerve-related side effects. For primary mediastinal large B-cell lymphoma, NCI describes dose-adjusted R-EPOCH or R-CHOP producing high cure rates while avoiding mediastinal radiation.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn stage, biomarker, and treatment details into questions for your oncology visit.

Build a treatment question list
Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Prepared by Cancer Explained's AI-assisted editorial system

Written from National Cancer Institute material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-13 what this meansLast updated: 2026-09-30Next planned review: 2027-01-20

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

Knowledge check

0 of 3 answered

  1. Q1.What is a regimen?
  2. Q2.What should you ask before starting a regimen?
  3. Q3.Why can two people receive different schedules?

This self-assessment checks understanding of educational content only. It is not medical advice.

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.